We discovered several chemokine receptor signatures on NK cells (N = 8) associated with the development of severe COVID-19, including upregulated CX3CR1 expression on early NK cells (Fig. 3a) and increased levels of CCR4, CCR9 and CXCR3 on terminal NK cells (Fig. 3b). This evidence concerns the gene CX3CR1 and COVID-19.